This particle, technically known as Lp(a), is similar to LDL cholesterol but more atherogenic. Its levels, largely determined by genetics, are barely modified by lifestyle. According to the hospital, elevated levels can increase the risk of myocardial infarction, stroke, and other cardiovascular diseases.

Cardiologist Joaquín Sánchez Prieto explained that lipoprotein(a) is an independent cardiovascular risk factor that can be elevated even with normal cholesterol levels. "That's why it's important to know it, as it allows us to identify patients with added risk and reclassify them," he stated.

The test to measure it is a simple blood analysis that is not usually included in routine tests, leading many people to be unaware of their levels. "We are facing a silent risk factor. It doesn't cause symptoms, but it does contribute to fat accumulation in the arteries and can accelerate the development of atherosclerotic cardiovascular disease," the specialist added.

Various scientific societies recommend measuring lipoprotein (a) at least once in a lifetime, especially in individuals with a family history of early cardiovascular disease or other risk factors. Due to its genetic nature, a single measurement is sufficient, as its levels remain stable throughout life.

"With a single measurement, we can know if the patient has a greater predisposition to cardiovascular events. This allows us to be proactive and stricter in controlling other factors such as LDL cholesterol, blood pressure, or lifestyle habits," noted Sánchez Prieto.

The Vithas Almería Hospital indicates that a "significant percentage" of the population has elevated lipoprotein (a) levels, reinforcing the importance of early detection. Although there are no specific treatments to lower it, knowing its value is "key" to improving cardiovascular prevention and personalizing treatment and follow-up.